Rankings
▼
Calendar
ACAD Q4 2016 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
ACAD
ACADIA Pharmaceuticals Inc.
$4B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
Gross Profit
$10M
80.7% margin
Operating Income
-$78M
-654.0% margin
Net Income
-$79M
-657.9% margin
EPS (Diluted)
$-0.65
QoQ Revenue Growth
+127.1%
Cash Flow
Operating Cash Flow
-$63M
Free Cash Flow
-$63M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$561M
Total Liabilities
$43M
Stockholders' Equity
$518M
Cash & Equivalents
$164M
← FY 2016
All Quarters
Q1 2017 →
